A team of scientists are reportedly developing a new ChatGPT-like generative artificial intelligence model which could design new drugs for treating disease. DrugAI, trained on data from the comprehensive public database BindingDB, can generate unique molecular structures from scratch, and then iteratively refine candidates, ensuring finalists exhibit strong binding affinities to respective drug targets -- crucial for the efficacy of …
